Search Results

Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time Redo hepatic artery reconstruction for thrombosis without...

Black patients and women have reduced access to liver transplantation for alcohol‐associated liver disease Characterization of social determinants of health of a liver transplant referral population...

Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes Liver transplantation with uncontrolled versus controlled DCD donors using...

Improved recurrence-free survival in patients with HCC with post-transplant plasma exchange AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective...

A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation Long-term outcomes (beyond 5 years) of liver transplant recipients—A transatlantic...

Secondary Sclerosing cholangitis Sclerosing cholangitis includes a group of chronic cholestatic liver diseases characterized by inflammation and fibrosis of bile ducts, leading to the formation of...

Why do we need TPE in liver disease? Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) are associated with high mortality unless treated appropriately.1 Therapeutic plasma exchange...

Pediatric Acute Liver Failure As outlined in the Liver Fellow Network post, Pediatric Acute Liver Failure: from Prompt Recognition and Management to Liver Transplant Considerations, pediatric acute...

https://www.nejm.org/doi/full/10.1056/NEJMoa2306185